Investors hoping to trade shares of Drake & Scull (DSI) on the Dubai Financial Market (DFM) will have to wait a little longer. The company's much-anticipated return after a five-year suspension due to restructuring has been delayed as DSI awaits final approvals from regulatory bodies.
The news comes just a day after DSI's initial announcement targeting a May 21st resumption of trading. A bourse filing clarified the situation, stating that DSI would provide updates on the approval process and a concrete restart date once the necessary regulatory and supervisory green light is secured.
The delay doesn't diminish the progress DSI has made in its turnaround efforts. The company successfully surpassed its recent capital increase target, raising 450 million Emirati dirhams (AED), exceeding the required amount by 150%. These funds were crucial for completing the restructuring process and paving the way for a return to the DFM.
DSI's suspension in 2019 stemmed from financial difficulties. The company underwent a significant restructuring program under new ownership, aiming to regain financial stability and investor confidence. The successful capital increase and the near-completion of the restructuring process were seen as positive indicators for DSI's market comeback.
While the exact reason for the delay in receiving approvals remains unclear, it highlights the importance of adherence to regulatory requirements. The DFM and its supervisory bodies have a responsibility to ensure the market operates with transparency and adheres to established financial regulations. This process, though potentially time-consuming, aims to protect investors and foster a healthy market environment.
The delay is likely to cause some disappointment among investors who were eagerly awaiting DSI's return. However, the positive developments in the restructuring process suggest that the wait might not be much longer. DSI's successful capital raise demonstrates a renewed level of investor confidence, and the company's commitment to completing the regulatory process signifies its dedication to a transparent and compliant return to the market.
Once DSI receives the necessary approvals, its re-entry onto the DFM will be closely watched. The company's performance can be seen as a litmus test for the success of its restructuring efforts. A strong showing could not only benefit DSI's shareholders but also inspire confidence in other companies undergoing similar turnaround initiatives.